OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, They have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. Thefirst product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of their pipeline.

OncoCell MDx

Similar companies